Immunome Ownership | Who Owns Immunome?
Immunome Ownership Summary
Immunome is owned by 88.55% institutional investors, 19.30% insiders. Blackrock is the largest institutional shareholder, holding 36.46% of IMNM shares. T. Rowe Price Small-Cap Stock is the top mutual fund, with 3.19% of its assets in Immunome shares.
IMNM Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Immunome | 88.55% | 19.30% | -7.85% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 3.76M | 36.46% | $45.48M |
| State street | 2.36M | 22.93% | $28.61M |
| T. rowe price investment management | 5.50M | 9.14% | $58.41M |
| Redmile group | 4.83M | 8.02% | $51.27M |
| Blackrock funding, inc. /de | 4.12M | 6.85% | $43.81M |
| Fmr | 3.92M | 6.51% | $41.62M |
| Ecor1 capital | 3.88M | 6.44% | $41.20M |
| Janus henderson group | 3.46M | 5.74% | $36.73M |
| Vanguard group | 3.00M | 4.99% | $31.90M |
| Price t rowe associates inc /md/ | 2.28M | 3.79% | $24.24M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Opaleye management | 2.04M | 3.79% | $21.66M |
| Redmile group | 4.83M | 3.57% | $51.27M |
| Ecor1 capital | 3.88M | 1.56% | $41.20M |
| Sofinnova investments | 746.82K | 0.58% | $7.93M |
| Prosight management, lp | 65.00K | 0.24% | $786.50K |
| Emfo | 11.84K | 0.13% | $143.20K |
| Three bridge wealth advisors | 27.61K | 0.10% | $293.27K |
| Woodline partners lp | 980.92K | 0.07% | $10.42M |
| Magnus financial group | 53.54K | 0.05% | $568.55K |
| Stoneridge investment partners | 11.55K | 0.04% | $123.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 3.76M | 0.00% | 2.93M |
| State street | 2.36M | 0.00% | 2.16M |
| Opaleye management | 2.04M | 3.79% | 802.50K |
| Jpmorgan chase | 648.61K | 0.00% | 624.04K |
| Renaissance | 316.00K | 0.01% | 304.70K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vestal point capital, lp | - | - | -1.00M |
| Avidity partners management lp | - | - | -873.89K |
| Brown advisory | - | - | -860.78K |
| Victory capital management | - | - | -730.78K |
| Tang capital management | - | - | -720.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Millennium management | 158.43K | 0.00% | 158.43K | $1.68M |
| Prosight management, lp | 65.00K | 0.24% | 65.00K | $786.50K |
| Alps advisors | 50.47K | 0.00% | 50.47K | $535.99K |
| Two sigma advisers, lp | 48.20K | 0.00% | 48.20K | $511.88K |
| Virtu financial | 45.74K | 0.03% | 45.74K | $486.00K |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -1.00 |
| Lindbrook capital | -38.00 |
| Russell investments group | -46.00 |
| Parallel advisors | -93.00 |
| Northwestern mutual wealth management | -100.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 123 | 1.65% | 53,309,287 | 3.16% | 88 | 1.20% | 69 | 4.55% | 35 | 25.00% |
| Sep 30, 2024 | 121 | 5.22% | 51,674,695 | 8.14% | 85 | 1.35% | 66 | -13.16% | 28 | 27.27% |
| Jun 30, 2024 | 115 | 7.48% | 47,785,575 | 30.06% | 79 | 2.12% | 76 | -12.64% | 22 | 83.33% |
| Mar 31, 2024 | 107 | 81.36% | 36,741,102 | 70.98% | 61 | 4.77% | 87 | 107.14% | 12 | 100.00% |
| Dec 31, 2023 | 59 | 55.26% | 21,488,187 | 810.23% | 35 | 231.10% | 42 | 180.00% | 6 | -40.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| T. Rowe Price Small-Cap Stock | 2.77M | 3.19% | - |
| T. Rowe Price US Small-Cap Core Equity | 1.96M | 3.14% | -111.98K |
| Fidelity Growth Compy Commingled Pl O | 1.79M | 2.97% | - |
| T. Rowe Price Health Sciences | 2.31M | 2.66% | - |
| Vanguard Total Stock Mkt Idx Inv | 2.24M | 2.65% | - |
| iShares Russell 2000 ETF | 1.87M | 2.15% | -16.17K |
| Fidelity Growth Compy Commingled Pl S | 1.83M | 2.11% | 2.89K |
| Vanguard US Total Market Shares ETF | 1.64M | 1.88% | - |
| T. Rowe Price Instl Small-Cap Stock | 1.48M | 1.71% | - |
| T. Rowe Price U.S. SC Core Eq Tr-Z | 924.04K | 1.48% | -101.63K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 25, 2025 | BIENAIME JEAN JACQUES | - | Buy | $60.68K |
| Mar 26, 2025 | SIEGALL CLAY B | President and CEO | Buy | $999.46K |
| Mar 24, 2025 | BIENAIME JEAN JACQUES | - | Buy | $57.47K |
| Mar 24, 2025 | Tsai Philip | Chief Technology Officer | Buy | $103.57K |
| Jan 31, 2025 | SIEGALL CLAY B | President and CEO | Buy | $1.16M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | 5 | - |
| 2024 Q4 | 4 | - |
| 2024 Q3 | 1 | 2 |
| 2024 Q2 | 3 | - |
| 2024 Q1 | - | - |
IMNM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools